Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-05-02 4:30 pm Purchase | 2022-04-21 | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | ADAGE CAPITAL PARTNERS GP L.L.C. | 93,333 8.080% | 93,333 (New Position) | Filing History |
| 2022-03-08 08:58 am Purchase | 2022-03-01 | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | Arkin Moshe | 60,874 5.380% | 60,874 (New Position) | Filing History |
| 2022-02-11 6:34 pm Purchase | 2021-12-31 | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | 683 Capital Management LLC | 110,000 9.700% | 20,547 (+22.97%) | Filing History |
| 2022-02-11 5:23 pm Sale | 2021-12-31 | 13D | EIGER BIOPHARMACEUTICALS INC C EIGR | Vivo Ventures VI LLC | 139 13.000% | -55,431 (-99.75%) | Filing History |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | BlackRock Inc. BLK | 82,432 7.300% | 3,256 (+4.11%) | Filing History |
| 2022-01-21 3:25 pm Purchase | 2021-12-27 | 13D | EIGER BIOPHARMACEUTICALS INC C EIGR | Ameriprise Financial, Inc. AMP | 234,961 20.750% | 39,639 (+20.29%) | Filing History |
| 2021-09-10 10:31 am Purchase | 2021-08-31 | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | Ameriprise Financial, Inc. AMP | 195,322 17.260% | 64,594 (+49.41%) | Filing History |